Sana Biotechnology (SANA)
2.69
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 4 Sana Biotechnology, Inc. For: Jun 04 Filed by: Yang Patrick Y
June 5, 2026 4:44 PM - SEC Filing
Form 4 Sana Biotechnology, Inc. For: Jun 04 Filed by: Rosiello Robert L.
June 5, 2026 4:41 PM - SEC Filing
Form 4 Sana Biotechnology, Inc. For: Jun 04 Filed by: Seitz Michelle
June 5, 2026 4:40 PM - SEC Filing
Form 4 Sana Biotechnology, Inc. For: Jun 04 Filed by: REICIN ALISE
June 5, 2026 4:38 PM - SEC Filing
Form 4 Sana Biotechnology, Inc. For: Jun 04 Filed by: Mulligan Richard
June 5, 2026 4:37 PM - SEC Filing
Form 4 Sana Biotechnology, Inc. For: Jun 04 Filed by: Bishop Hans Edgar
June 5, 2026 4:35 PM - SEC Filing
Form 4 Sana Biotechnology, Inc. For: Jun 04 Filed by: Bilenker Joshua H.
June 5, 2026 4:33 PM - SEC Filing
Form 4 Sana Biotechnology, Inc. For: Jun 04 Filed by: NELSEN ROBERT
June 5, 2026 4:25 PM - SEC Filing
Form 8-K Sana Biotechnology, Inc. For: Jun 04
June 5, 2026 4:06 PM - SEC Filing
Sana Biotechnology to Present at June 2026 Investor Conferences
May 27, 2026 4:05 PM - StreetInsider
Form SCHEDULE 13G Sana Biotechnology, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
May 21, 2026 9:13 PM - SEC Filing
Form 8-K Sana Biotechnology, Inc. For: May 15
May 15, 2026 4:11 PM - SEC Filing
Sana Biotechnology raises $69 million through share sale
May 15, 2026 9:00 AM - StreetInsider
Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility
May 15, 2026 9:00 AM - Globe NewsWire
Sana Biotechnology presents preclinical data for in vivo CAR T therapy
May 12, 2026 4:05 PM - StreetInsider
Sana Biotechnology reports preclinical data for in vivo CAR T therapy
May 12, 2026 4:05 PM - StreetInsider
Sana presents preclinical data for in vivo CAR T cell therapy SG293
May 12, 2026 4:05 PM - StreetInsider
Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs
May 12, 2026 4:05 PM - StreetInsider
Sana Biotechnology, Inc. (SANA) Misses Q1 EPS by 1c
May 11, 2026 4:28 PM - StreetInsider
Form S-8 Sana Biotechnology, Inc.
May 11, 2026 4:18 PM - SEC Filing
Form 10-Q Sana Biotechnology, Inc. For: Mar 31
May 11, 2026 4:11 PM - SEC Filing
Form 8-K Sana Biotechnology, Inc. For: May 11
May 11, 2026 4:09 PM - SEC Filing
Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates
May 11, 2026 4:05 PM - StreetInsider
Rodman & Renshaw Starts Sana Biotechnology (SANA) at Buy, PT $16
May 11, 2026 7:31 AM - StreetInsider
Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference
May 5, 2026 4:05 PM - StreetInsider
Sana Biotechnology to present SG293 CAR T data at ASGCT meeting
April 27, 2026 4:30 PM - StreetInsider
Sana Biotechnology to present SG293 preclinical data at gene therapy meeting
April 27, 2026 4:30 PM - StreetInsider
Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting
April 27, 2026 4:30 PM - Globe NewsWire
Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting
April 27, 2026 4:30 PM - StreetInsider
Form ARS Sana Biotechnology, Inc. For: Dec 31
April 24, 2026 6:30 AM - SEC Filing
Form DEFA14A Sana Biotechnology, Inc.
April 24, 2026 6:25 AM - SEC Filing
Form DEF 14A Sana Biotechnology, Inc. For: Jun 04
April 24, 2026 6:21 AM - SEC Filing
Form 8-K Sana Biotechnology, Inc. For: Apr 22
April 24, 2026 6:05 AM - SEC Filing
Sana Biotechnology (SANA) Reiterated at Market Outperform by Citizens on Mayo Partnership
April 15, 2026 5:47 AM - StreetInsider
Sana Biotechnology (SANA) PT Raised to $7 at Wedbush
April 14, 2026 8:54 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Sana Biotechnology (SANA)
April 14, 2026 6:50 AM - StreetInsider
Form 424B5 Sana Biotechnology, Inc.
April 13, 2026 5:04 PM - SEC Filing
Sana Biotechnology raises $25 million from Mayo Clinic in stock deal
April 13, 2026 4:13 PM - StreetInsider
Form 8-K Sana Biotechnology, Inc. For: Apr 10
April 13, 2026 4:11 PM - SEC Filing
Sana Biotechnology shares gain on Mayo Clinic partnership
April 13, 2026 4:11 PM - StreetInsider
Sana Biotechnology partners with Mayo Clinic on diabetes cell therapy
April 13, 2026 4:05 PM - StreetInsider
Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451
April 13, 2026 4:05 PM - StreetInsider
Form 4 Sana Biotechnology, Inc. For: Apr 06 Filed by: Bishop Hans Edgar
April 8, 2026 4:16 PM - SEC Filing
Form 3 Sana Biotechnology, Inc. For: Mar 24 Filed by: PATEL DHAVALKUMAR DHIRAJLAL
March 27, 2026 4:16 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Sana Biotechnology (SANA)
March 16, 2026 6:50 AM - StreetInsider
Morgan Stanley Reiterates Overweight Rating on Sana Biotechnology (SANA) after "meaningful platform level de-risking event"
March 13, 2026 1:05 PM - StreetInsider
Sana Biotechnology reports 14-month type 1 diabetes trial results
March 13, 2026 9:00 AM - StreetInsider
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
March 13, 2026 9:00 AM - StreetInsider
Full Article List
